Unnatural amino acids for the study of chemokine receptor structure and dynamics

Drug Discovery Today: Technologies

Volumn 9, Issue 4, 2012, Pages

  Siderius, Marco ^a   Wal, Marjolein ^a   Scholten, Danny J ^a   Smit, Martine J ^a   Sakmar, Thomas P ^b   Leurs, Rob ^a   De Graaf, Chris ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYLTYROSINE; 3 (2 NAPHTHYL)ALANINE; 3 ACETYLPHENYLALANINE; 3 AMINOTYROSINE; 3 CYANOPHENYLALANINE; 3 NITROTYROSINE; 4 ACETYLPHENYLALANINE; 4 AMINOPHENYLALANINE; 4 AZIDOPHENYLALANINE; 4 BORONOPHENYLALANINE; 4 BROMPHENYLALANINE; 4 CYANOPHENYLALANINE; 4 FLUOROPHENYLALANINE; 4 IODOPHENYLALANINE; 4 ISOPROPYLPHENYLALANINE; 4 ISOPRPOYLTHIOCARBONYL PHENYLALANINE; 4 METHYLTHIOCARBONYL PHENYLALANINE; 4 NITROPHENYLALANINE; 4 PROPARGYLOXYPHENYLALANINE; 4 TRIFLUOROMETHOXY PHENYLALANINE; AMINO ACID; AMINO ACID TRANSFER RNA LIGASE; CHEMOKINE RECEPTOR CCR5; G PROTEIN COUPLED RECEPTOR; HOMOCYSTEINE; IODOTYROSINE; LEVODOPA; PHENYLSELENOCYSTEINE; TRANSFER RNA; UNCLASSIFIED DRUG; UNNATURAL AMINO ACID;

CODON; CONFORMATIONAL TRANSITION; DRUG PROTEIN BINDING; ESCHERICHIA COLI; GENETIC CODE; GENETIC ENGINEERING; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; LIGAND BINDING; MOLECULAR DYNAMICS; MOLECULAR PROBE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN STRUCTURE; REVIEW; RNA SYNTHESIS; RNA TRANSLATION; STOP CODON; ULTRAVIOLET IRRADIATION;

EID: 84873099189     PISSN: None     EISSN: 17406749     Source Type: Journal    
DOI: 10.1016/j.ddtec.2012.07.008     Document Type: Review

References (60)

1. Viola, A. and Luster, A.D. (2008) Chemokines and their receptors: drug targets in immunity and inflammation. Annu. Rev. Pharmacol. Toxicol. 48, 171-197
2. Zlotnik, A. and Yoshie, O. (2000) Chemokines: a new classification system and their role in immunity. Immunity 12, 121-127
3. Murphy, P.M. et al. (2000) International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 52, 145-176
4. Alexander, S.P. et al. (2011) Guide to receptors and channels (GRAC), 5th edition. Br. J. Pharmacol. 164 (Suppl. 1), S1-S324
5. Casarosa, P. et al. (2005) CC and CX3C chemokines differentially interact with the N terminus of the human cytomegalovirus-encoded US28 receptor. J. Biol. Chem. 280, 3275-3285
6. Kashiwazaki, M. et al. (2003) A high endothelial venule-expressing promiscuous chemokine receptor DARC can bind inflammatory, but not lymphoid, chemokines and is dispensable for lymphocyte homing under physiological conditions. Int. Immunol. 15, 1219-1227
7. Gosling, J. et al. (2000) Cutting edge: identification of a novel chemokine receptor that binds dendritic cell- and T cell-active chemokines including ELC, SLC, and TECK. J. Immunol. 164, 2851-2856
8. Kenakin, T. (2011) Functional selectivity and biased receptor signaling. J. Pharmacol. Exp. Ther. 336, 296-302
9. Murphy, P. (2001) Chemokines and the molecular basis of cancer metastasis. N. Engl. J. Med. 345, 3
10. Balkwill, F. (2004) Cancer and the chemokine network. Nat. Rev. Cancer 4, 540-550
11. Charo, I.F. and Ransohoff, R.M. (2006) The many roles of chemokines and chemokine receptors in inflammation. N. Engl. J. Med. 354, 610-621
12. Berger, E.A. et al. (1999) Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17, 657-700
13. Scholten, D. et al. (2011) Pharmacological characterisation of a smallmolecule agonist for the chemokine receptor CXCR3. Br. J. Pharmacol. 165, 1617-1643
14. Schall, T.J. and Proudfoot, A.E. (2011) Overcoming hurdles in developing successful drugs targeting chemokine receptors. Nat. Rev. Immunol. 11, 355-363
15. Gulick, R.M. et al. (2008) Maraviroc for previously treated patients with R5 HIV-1 infection. N. Engl. J. Med. 359, 1429-1441
16. Winkler, I.G. et al. (2012) Hematopoietic stem cell mobilizing agents GCSF, cyclophosphamide or AMD3100 have distinct mechanisms of action on bone marrow HSC niches and bone formation. Leukemia 26, 1594-1601
17. Dar, A. et al. (2011) Rapid mobilization of hematopoietic progenitors by AMD3100 and catecholamines is mediated by CXCR4-dependent SDF-1 release from bone marrow stromal cells. Leukemia 25, 1286-1296
18. Jähnichen, S. et al. (2010) CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells. Proc. Natl. Acad. Sci. U. S. A. 107, 20565-20570
19. Kobilka, B.K. (2011) Structural insights into adrenergic receptor function and pharmacology. Trends Pharmacol. Sci. 32, 213-218
20. Katritch, V. et al. (2012) Diversity and modularity of G protein-coupled receptor structures. Trends Pharmacol. Sci. 33, 17-27
21. Salon, J.A. et al. (2011) The significance of G protein-coupled receptor crystallography for drug discovery. Pharmacol. Rev. 63, 901-937
22. Kufareva, I. et al. (2011) Status of GPCR modeling and docking as reflected by community-wide GPCR Dock 2010 assessment. Structure 19, 1108-1126
23. Cohen, G.N. and Cowie, D.B. (1957) Total replacement of methionine by selenomethionine in the proteins of Escherichia coli. C. R. Hebd. Seances Acad. Sci. 244, 680-683
24. Muir, T.W. (2003) Semisynthesis of proteins by expressed protein ligation. Annu. Rev. Biochem. 72, 249-289
25. Kimmerlin, T. and Seebach, D. (2005) '100 years of peptide synthesis': ligation methods for peptide and protein synthesis with applications to beta-peptide assemblies. J. Pept. Res. 65, 229-260
26. Hackenberger, C.P. and Schwarzer, D. (2008) Chemoselective ligation and modification strategies for peptides and proteins. Angew. Chem. Int. Ed. Engl. 47, 10030-10074
27. Arnold, U. (2009) Incorporation of non-natural modules into proteins: structural features beyond the genetic code. Biotechnol. Lett. 31, 1129-1139
28. Wang, Q. et al. (2009) Expanding the genetic code for biological studies. Chem. Biol. 16, 323-336
29. Liu, C.C. and Schultz, P.G. (2010) Adding new chemistries to the genetic code. Annu. Rev. Biochem. 79, 413-444
30. Means, G.E. and Feeney, R.E. (1990) Chemical modifications of proteins: history and applications. Bioconjug. Chem. 1, 2-12
31. Durek, T. and Becker, C.F. (2005) Protein semi-synthesis: new proteins for functional and structural studies. Biomol. Eng. 22, 153-172
32. Perler, F.B. and Adam, E. (2000) Protein splicing and its applications. Curr. Opin. Biotechnol. 11, 377-383
33. Wang, L. and Schultz, P.G. (2004) Expanding the genetic code. Angew. Chem. Int. Ed. Engl. 44, 34-66
34. Zhang, Z. et al. (2004) A new strategy for the synthesis of glycoproteins. Science 303, 371-373
35. Xu, R. et al. (2004) Site-specific incorporation of the mucin-type Nacetylgalactosamine-alpha-O-threonine into protein in Escherichia coli. J. Am. Chem. Soc. 126, 15654-15655
36. Jackson, J.C. et al. (2007) Site-specific incorporation of a (19)F-amino acid into proteins as an NMR probe for characterizing protein structure and reactivity. J. Am. Chem. Soc. 129, 1160-1166
37. Daggett, K.A. and Sakmar, T.P. (2011) Site-specific in vitro and in vivo incorporation of molecular probes to study G-protein-coupled receptors. Curr. Opin. Chem. Biol. 15, 392-398
38. Ye, S.X. et al. (2008) Site-specific incorporation of keto amino acids into functional G protein-coupled receptors using unnatural amino acid mutagenesis. J. Biol. Chem. 283, 1525-1533
39. Ye, S. et al. (2009) FTIR analysis of GPCR activation using azido probes. Nat. Chem. Biol. 5, 397-399
40. Ye, S. et al. (2010) Tracking G-protein-coupled receptor activation using genetically encoded infrared probes. Nature 464, 1386-1389
41. Kehoe, J.W. and Bertozzi, C.R. (2000) Tyrosine sulfation: a modulator of extracellular protein-protein interactions. Chem. Biol. 7, R57-R61
42. Veldkamp, C.T. et al. (2008) Structural basis of CXCR4 sulfotyrosine recognition by the chemokine SDF-1/CXCL12. Sci. Signal. 1, ra4
43. Veldkamp, C.T. et al. (2006) Recognition of a CXCR4 sulfotyrosine by the chemokine stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12). J. Mol. Biol. 359, 1400-1409
44. Mecozzi, S. et al. (1996) Cation-pi interactions in aromatics of biological and medicinal interest: electrostatic potential surfaces as a useful qualitative guide. Proc. Natl. Acad. Sci. U. S. A. 93, 10566-10571
45. Torrice, M.M. et al. (2009) Probing the role of the cation-pi interaction in the binding sites of GPCRs using unnatural amino acids. Proc. Natl. Acad. Sci. U. S. A. 106, 11919-11924
46. Grunbeck, A. et al. (2011) Mapping the ligand-binding site on a G proteincoupled receptor (GPCR) using genetically encoded photocrosslinkers. Biochemistry 50, 3411-3413
47. Grunbeck, A. et al. (2012) Genetically-encoded photocrosslinkers map the binding site of an allosteric drug on a G protein-coupled receptor. ACS Chem. Biol. 7, 967-972
48. Wood, A. and Armour, D. (2005) The discovery of the CCR5 receptor antagonist, UK-427,857, a new agent for the treatment of HIV infection and AIDS. Prog. Med. Chem. 43, 239-271
49. Tikhonova, I.G. and Costanzi, S. (2009) Unraveling the structure and function of G protein-coupled receptors through NMR spectroscopy. Curr. Pharm. Des. 15, 4003-4016
50. Bokoch, M.P. et al. (2010) Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor. Nature 463, 108-112
51. Radu, I. et al. (2009) Time-resolved methods in biophysics. 10. Timeresolved FT-IR difference spectroscopy and the application to membrane proteins. Photochem. Photobiol. Sci. 8, 1517-1528
52. Wang, J. et al. (2006) A genetically encoded fluorescent amino acid. J. Am. Chem. Soc. 128, 8738-8739
53. Summerer, D. et al. (2006) A genetically encoded fluorescent amino acid. Proc. Natl. Acad. Sci. U. S. A. 103, 9785-9789
54. Tsao, M.L. et al. (2006) The genetic incorporation of a distance probe into proteins in Escherichia coli. J. Am. Chem. Soc. 128, 4572-4573
55. Wang, W. et al. (2007) Genetically encoding unnatural amino acids for cellular and neuronal studies. Nat. Neurosci. 10, 1063-1072
56. Van Arnam, E.B. et al. (2011) Dissecting the functions of conserved prolines within transmembrane helices of the D2 dopamine receptor. ACS Chem. Biol. 6, 1063-1068
57. Bose, M. et al. (2006) The incorporation of a photoisomerizable amino acid into proteins in E. coli. J. Am. Chem. Soc. 128, 388-389
58. Chin, J.W. and Schultz, P.G. (2002) In vivo photocrosslinking with unnatural amino acid mutagenesis. Chembiochem 3, 1135-1137
59. Xu, R. et al. (2004) Site-specific incorporation of the mucin-type Nacetylgalactosamine-a-O-threonine into protein in Escherichia coli. J. Am. Chem. Soc. 126, 15654-15655
60. Jackson, J.C. et al. (2007) Site-specific incorporation of a 19F-amino acid into proteins as an NMR probe for characterizing protein structure and reactivity. J. Am. Chem. Soc. 129, 1160-1166